Marty Chilberg's  Instablog

Marty Chilberg
Send Message
Marty Chilberg is a seasoned financial professional with over 30 years of executive leadership, board, consulting and advisory experience.  He began his career as a certified public accountant (CPA). He moved to Silicon Valley in 1981 to begin his career in the software industry, working for... More
  • Quest Diagnostics NIPT Comments $DGX 0 comments
    Apr 24, 2014 8:27 PM | about stocks: DGX

    Stephen Rusckowski - President and CEO opening remarks

    - These are all exciting opportunities for us. This last win is further evidence that hospital leaders are open to new ideas to help them manage the emerging challenges of reimbursement pressure and lower utilization. We have the experience and expertise to help tailor solutions for the needs to hospitals of all shapes and sizes.

    Finally, we are seeing results from our focus on specific disease stay-in conditions. We talked about the strong growth in our Wellness business, combining with Summit Health, will strengthen this business. We have also seen solid growth in our toxicology and prescription drug monitoring offerings, as well as improvements in Hepatitis C, BRC Advantage, and non-invasive prenatal testing.

    Question-and-Answer Session

    Stephen Rusckowski - President and CEO

    But also non-evasive prenatal testing is a growth market for us, we're focused on that as well. We feel that with the progress we're making there we think it's a fast growth market place. It is a great example where medical guidelines are actually stimulating demand for us and we're taking advantage of those new guidelines of the market place.

    Mark Guinan - CFO

    Yeah. We have successfully negotiated reimbursement rates with the typical health plans that we contract with. We feel good about the prices again similar to what Steve said on expectation as not just volume but the reimbursement rates that we thought we could achieve. We're feeling good about those. So, the reimbursement environment is reasonable certainly like any other task that starts to get lot more attention - the payers start to put some things in place like pre-authorizations, etc. that can slow down the process, make things a little cumbersome and you're going to work through some of those issues initially to smooth up the process but no major hurdles on reimbursement in those two categories right now.

    Stocks: DGX
Back To Marty Chilberg's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.